Title: Nair HB, et al. Discovery and preclinical pharmacology of EC330: A first-in-class leukemia inhibitory factor (LIF) inhibitor
1231889-53-4 | BMS-935177 | AA01EO5Q | MFCD30470964
1964515-43-2 | LDH-IN-1 | AA01EOBO | MFCD31657379
1218816-71-7 | SK1-IN-1 | AA01EOGV | MFCD31382196
1610358-56-9 | (+)-BAY-1251152 | AA01EONA | MFCD31619237
1427325-32-3 | (2-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone | AA01EOTB | MFCD18382133
1630022-98-8 | [1-(5-fluoropentyl)-6-hydroxy-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone | AA01EP27
1646795-60-9 | 6Z-[2-oxo-4-(2-phenylethyl)-3-oxetanylidene],hexanamide | AA01EPCC
682745-40-0 | N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-urea,monohydrate | AA01EPIR
142147-67-9 | 1-[[[(1R)-1-[3-[2-(7-chloro-2-quinolinyl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-cyclopropaneaceticacid | AA01EPOQ
95037-06-2 | N-[(1S,2S,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-octadecanamide | AA01EPVC